FAIR VALUE MEASUREMENTS - Schedule of Financial Assets and Liabilities (Details) - USD ($)	Mar. 31, 2021		Feb. 04, 2021	Dec. 31, 2020
Assets, at fair value
Investments held in Trust Account	$ 1,000,040,379			$ 0
Liabilities, at fair value
Warrant liabilities	31,040,535	[1]	$ 55,407,948	$ 0	[1]
Quoted Prices in Active Markets (Level 1)
Assets, at fair value
Investments held in Trust Account	1,000,040,379
Quoted Prices in Active Markets (Level 1) | Warrant Liabilities | Public Warrants
Liabilities, at fair value
Warrant liabilities	17,500,000
Quoted Prices in Active Markets (Level 1) | Warrant Liabilities | Private Placement Warrants
Liabilities, at fair value
Warrant liabilities	0
Significant Other Observable Inputs (Level 2)
Assets, at fair value
Investments held in Trust Account	0
Significant Other Observable Inputs (Level 2) | Warrant Liabilities | Public Warrants
Liabilities, at fair value
Warrant liabilities	0
Significant Other Observable Inputs (Level 2) | Warrant Liabilities | Private Placement Warrants
Liabilities, at fair value
Warrant liabilities	0
Significant Other Unobservable Inputs (Level 3)
Assets, at fair value
Investments held in Trust Account	0
Significant Other Unobservable Inputs (Level 3) | Warrant Liabilities | Public Warrants
Liabilities, at fair value
Warrant liabilities	0
Significant Other Unobservable Inputs (Level 3) | Warrant Liabilities | Private Placement Warrants
Liabilities, at fair value
Warrant liabilities	$ 13,540,535

[1] In April 2021, the Company concluded that, because of a misapplication of the accounting guidance related to its Public and Private Placement warrants, the Company is restating its previously issued balance sheet dated February 4, 2021, filed on Form 8-K on February 10, 2021, in this Quarterly Report. The impact to the balance sheet resulted in a $55.4 million increase to the warrant liabilities line item and offsetting decrease to the Class A ordinary shares subject to possible redemption line item as of February 4, 2021 (see Note 2). Prospectively, the Company will adjust the instruments to fair value at each reporting period and the liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statement of operations.